A Phase 1 Study of HMPL-306 in Locally Advanced Solid Tumors with IDH mutations
2020-306-GLOB2
Phase 1 other active
Quick answer
A Phase 1 Study of HMPL-306 in Locally Advanced Solid Tumors with IDH mutations for - Locally advanced or metastatic solid tumors - Cholangiocarcinoma - Skeletal chondrosarcoma - Low-grade glioma - Any other solid tumor harboring an IDH mutation is a Phase 1 program (other) at Hutchmed Europe B.V. with 1 ClinicalTrials.gov record(s).
Program details
- Company
- Hutchmed Europe B.V.
- Indication
- - Locally advanced or metastatic solid tumors - Cholangiocarcinoma - Skeletal chondrosarcoma - Low-grade glioma - Any other solid tumor harboring an IDH mutation
- Phase
- Phase 1
- Modality
- other
- Status
- active